| List Abbreviation | List Type | | List Category | Green Screen Hazard | Green Screen Benchmark |
| NIOSH | Authoritative | A | Occupational Cancer | H | 1 |
| NTP-C | Authoritative | A | Known to be a human carcinogen | H | 1 |
| NTP-C | Authoritative | A | Reasonably Anticipated to be a human carcinogen | H | 1 |
| NTP-C | Authoritative | A | Chemicals of high concern | H | 1 |
| SVHC | Authoritative | A | Extremely Hazardous Substance, may be Green Screen vH or H | vH | 1 |
| IRIS (1999, 2005) | Authoritative | A | Carcinogenic to humans | H | 1 |
| IRIS (1999, 2005) | Authoritative | A | Likely to be carcinogenic to humans | H | 1 |
| IRIS (2005) | Authoritative | B | Suggestive evidence of carcinogenic potential | M | 2 |
| IRIS (1999, 2005) | Authoritative | A | Not likely to be carcinogenic to humans | L | N/A |
| IRIS (1999) | Authoritative | B | Suggestive evidence of carcinogenicity, but not sufficient to assess human carcinogenic potential | M | 2 |
| IRIS (1996) | Authoritative | A | Known/likely human carcinogen | H | 1 |
| IRIS (1986) | Authoritative | A | Group A - Human Carcinogen | H | 1 |
| IRIS (1986) | Authoritative | A | Group B1 - Probably human carcinogen | H | 1 |
| IRIS (1986) | Authoritative | A | Group B2 - Probably human carcinogen | H | 1 |
| IRIS (1986) | Authoritative | B | Group C - “Possible human carcinogen” | M | 2 |
| IRIS (1986) | Reference | | Group D – “Not classifiable as to human carcinogenicity”? (can be either not likely or a data gap) | Unknown | |
| IRIS (1986) | Authoritative | A | Group E - “Evidence of non-carcinogenicity to humans” | L | N/A |
| IARC | Authoritative | A | Group 1: Agent is carcinogenic to humans | H | 1 |
| IARC | Authoritative | A | Group 2A: Agent is probably carcinogenic to humans | H | 1 |
| IARC | Authoritative | B | Group 2b: Possibly carcinogenic to humans | M | 2 |
| IARC | Reference | | Group 3: Not classifiable as to carcinogenicity to humans | Unknown | N/A |
| IARC | Authoritative | A | Group 4: Probably not carcinogenic to humans | L | N/A |
| PROP 65 | Authoritative | A | Known to the state to cause cancer | H | 1 |
| PROP 65 | Authoritative | A | Known to the state to cause reproductive effects | H | 1 |
| EU CMR List | Authoritative | A | Carcinogen Category 1: “known” | H | 1 |
| EU CMR List | Authoritative | A | Carcinogen Category 2: “should be considered carcinogenic to humans” | H | 1 |
| EU CMR List | Authoritative | B | Carcinogen Category 3: “possibly carcinogenic to humans” (listed as Carc. Cat. 3) | M | 2 |
| EU CMR List | Authoritative | A | Mutagen Category 1: “Substances known to be mutagenic to man” | H | 1 |
| EU CMR List | Authoritative | A | Mutagen Category 2: “Substances which should be regarded as if they are mutagenic to man” | H | 1 |
| EU CMR List | Authoritative | B | Mutagen Category 3: Possible | M | 2 |
| EU CMR List | Authoritative | A | Reproduction Category 1: “known” to impair fertility in humans or cause developmental toxicity in humans” | H | 1 |
| EU CMR List | Authoritative | A | Reproduction Category 2: “should be regarded as if” they impair fertility to humans or cause developmental toxicity to humans” | H | 1 |
| EU CMR List | Authoritative | B | Reproduction Category 3: possible | M | 2 |
| G&L | Screening | A | Developmental Neurotoxicant | H | 1 |
| G&L | Screening | A | Neurotoxicant | M | 2 |
| EU ED | Screening | A | Category 1 (“at least one in-vivo study providing clear evidence for endocrine disruption in at least one species using intact animals”), | H | 2 |
| EU ED | Screening | A | Category 2 (“Potential for endocrine disruption. In-vitro data indicating potential for endocrine disruption in intact organisms. Also includes effects in-vivo that may, or may not, be ED-mediated.”) | M | 2 |
| EU ED | Screening | B | Category 3a (“No scientific basis for inclusion in list; ED Studies available but no indication of ED effects" | L | |
| EU ED | Reference | | Category 3b (“Substances with no or insufficient data gathered") | Unknown | |
| EU DSD | Authoritative | A | R45 “May cause cancer” | H | 1 |
| EU DSD | Authoritative | A | R49 “May cause cancer by inhalation” | H | 1 |
| EU DSD | Authoritative | B | R40 “Limited Evidence of Carcinogenic Effects” | M | 2 |
| EU DSD | Authoritative | A | R46 “May cause heritable genetic damage“ | H | 1 |
| EU DSD | Authoritative | B | R68 “May cause irreversible effects“ | M | 2 |
| EU DSD | Authoritative | A | R60 “May impair fertility” | H | 1 |
| EU DSD | Authoritative | A | R61 “May cause harm to the unborn child” | H | 1 |
| EU DSD | Authoritative | B | R62 “Possible risk of impaired fertility” | M | 2 |
| EU DSD | Authoritative | B | R63 “Possible risk of harm to the unborn child” | M | 2 |
| EU DSD | Authoritative | B | R64 “May cause harm to breastfed babies” | M | 2 |
Uploading ....